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ABSTRACT 
Objective: The purpose of this study was to determine a sterile 0.5% chloramphenicol eye drop formula with the best potency of antibacterial by 
determining the appropriate sterilization method and the supporting pH. 
Methods: 0.5% chloramphenicol was formulated with 0.01% thimerosal, which act as a bactericide and combines with borate buffer to produce eye 
drop formulas with variations in pH (6.8, 7.0 and 7.4). All formulas were stored at room temperature for 28 d and were evaluated, including: 
organoleptic of the preparations, sterility, pH stability, and the antibacterial potency of chloramphenicol in eye drops. 
Results: All dosage formulas did not undergo photodegradation reactions which were marked by no change in color until the end of the storage 
period. However, the formula with pH 6.8 which was sterilized by heating in a presence of bactericide, showed the presence of more particulate 
precipitates than in the pH 6.8 formula which was sterilized using membrane filter bacteria. However, both methods of sterilization produced sterile 
chloramphenicol eye drops. The preparation using a method of heat sterilization with bactericide decreased the pH greater than the preparation 
using a sterile bacterial filter sterilization method. C2 preparations at pH 7.0 and sterilized using the bacterial filter membrane sterilization method 
were more stable because they had the smallest pH change of 0.05 and the percentage reduction in antibacterial potential was smaller at 1.15%. 
Conclusion: The best treatment for the chloramphenicol eye drop was kept the pH formula at pH 7 and sterilized using bacterial filter membrane 
sterilization method. 
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Eye infections occur when pathogenic microorganisms 
contaminated and multiply in the eye. Eye contaminations related to 
the exposed of the eye to the external environment, because the eyes 
are very sensitive to external. In addition, the airborne pathogen 
that contaminated hands can be an alternative source for eye 
infection [1]. Conjunctivitis, endophthalmitis and bacterial keratitis 
are some kinds of eye infection caused by various kinds of bacteria 
[2-4]. The eye is a challenging organ for drug delivery because of its 
unique anatomy with restriction of drug absorbed into the deep 
tissues [5]. Chloramphenicol is one of the topical antibiotic 
occasionally used in the eye infection treatment because of its broad 
antibacterial spectrum and its capability to penetrate into the 
aqueous humor and ocular tissues [6]. Chloramphenicol is active 
against both Gram positive and Gram-negative bacteria. 
Chloramphenicol acts by binding to the 50S ribosomal subunit of 
bacteria and inhibiting peptidyl transferase. This enzyme catalyzes 
the growing polypeptide chain by forming the peptide bonds 
between adjacent amino acids [7]. The topical application of 
Chloramphenicol is known to be relatively safe, but its systemic 
administration may have fatal side effects, such as aplastic anemia 
and bone marrow suppression [8]. Because of this reason, 
chloramphenicol use is restricted to ophthalmic applications or 
other infection treatment when the alternative treatments are not 
available [9]. However, chloramphenicol has been used as the gold 
standard of antibiotic in ophthalmic preparation and being text 
prescribed for 55% patient with red eyes [10, 11]. The 
chloramphenicol has treated of 91% to 93% in ocular infections [12, 
13] and can inhibit more than 94% of eye pathogens [10]. 
The source of eye infection is not only from the contamination 
during the preparation used, but it may come from ophthalmic 
solutions itself [14]. The occurrence of endophthalmitis and 
bacterial keratitis had been reported to be correlated with 
contaminated topical eye medications case [3, 4
The eye drops can be sterilized using chemical and mechanical 
method. The common sterilization of eye drops using the chemical 
method is sterilization by heating with a bactericide at 98-100 °C fro 
30 min by denaturing the bacterial protein as its mechanism. But 
chloramphenicol was subjected to forced degradation by chemical 
oxidation, alkali, acid, and heat [16]. Chloramphenicol heating at a 
temperature of 100 °C for 30 min resulted in degradation of 4% and 
by heating 115 °C with the same time, degradation of 10% was 
produced. This degradation can reduce the stability and efficacy of 
chloramphenicol in eye drops [17, 18]. Another study compared that 
15% hydrolysis of chloramphenicol may occurred after autoclaving 
the eye drops, and 3 to 4% after heating with a bactericide. This 
combination of methods was also considered on the fact that spore 
contaminants in the preparation cannot be killed only by using 
bactericides but also require heating. It has been reported that 
bacterial spores can survive after exposed by gamma irradiation, 
then can be inactivated by heat treatment [19-22]. Others study also 
observed that spores of bacteria showed higher sensitivity to 
inactivated by treatment using bactericides at normal temperatures 
after surviving at gamma irradiation sublethal doses [23]. For this 
reason, the sterilization process using heat with a bactericide is 
investigated in this study and compared its efficacy against the 
mechanical method of sterilization without heat. Meanwhile, for the 
mechanical method, it can be employed by sieving the bacterial cell ]. The contamination 
may lead to the decreasing of efficacious treatment because the 
contaminants can alter the pH of ophthalmic solution [15]. 
Therefore, most of ophthalmic preparations always use 
preservatives to inhibit the growth of microbial contamination. 
Beside using preservatives or bactericide, the sterility of the 
ophthalmic solution product also must be ensured. But the 
determination of the sterilization method used must consider the 
stability of the active substance in the preparation. The proper 
sterilization method can optimize the product sterility level and 
maintain antibacterial stability from eye drops. 
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using membrane filter. This sterilization method is used to sterilize a 
solution that is not heat resistant. The benefits of filter sterilization 
include the accuracy of filtering the solution in small amounts, the 
ability to effectively sterilize compounds that are not heat resistant, 
the equipment used is relatively cheap and can remove living and 
dead microbes and particles from solution [24]. Besides the heating 
effect, the stability of eye drops can also be affected by pH. Changes 
in pH can affect the rate of a chloramphenicol decomposition 
reaction. But the pH changes can be prevented by adding buffers and 
adjusting pH through the addition of acids or bases. In addition to 
maintaining chemical stability, the addition of buffers and pH 
regulation in eye drops can also reduce the discomfort feeling and 
increase the solubility of medicinal ingredients [25]. The stability of 
chloramphenicol eye drops can be improved by adding borate buffer 
to the pH stability of 7.0-7.5 [18, 25]. Therefore, the effect of 
different sterilization method was evaluated by measuring the 
antibacterial potency of 0.5% chloramphenicol in eye drop formula 
with optimizing the pH formula to determine the most stable eye 
drops formula.  
MATERIALS AND METHODS 
Materials 
Components of eye drops formula were consisted of 
chloramphenicol (PT. Cendo Indonesia®), thimerosal (PT. Cendo 
Indonesia®), boric acid (Merck®), sodium tetraborate (Merck®), and 
redistillata water (PT. Ikapharmindo Indonesia®). The growth media 
used in this study were Tryptone Soya Agar (TSA-Oxoid®), Fluid 
Tetrathionate Medium (FTM-Oxoid®), Trypticase Soy Broth (TSB-
Pronadisa®), Sabouraud Dextrose Agar (SDA-Oxoid®), Pepton 
(Oxoid®), and Mueller Hinton Agar (MHA-Oxoid®
Eye drops formulation  
). The tested 
bacteria used for sterility test were Candida albicans ATCC®10231 
and Bacillus subtilis ATCC® 6633, meanwhile in the antibiotic 
potency test was Escherichia coli ATCC 25922, obtained from the 
Laboratory of Microbiology, Padjadjaran University, Indonesia. 
Indonesian Pharmacopoeia reference standard of chloramphenicol 
was used in a standard solution of 0.5% chloramphenicol in eyes 
drop preparation for the potency test. 
Chloramphenicol eye drops with different sterilization methods 
(formula B = heating with bactericidal and formula C = Sterile 
membrane filter bacteria) and each formula made in three pH 
variations using borate buffer (pH = 6.8; pH = 7.0 and pH = 7.4). The 
details formula was performed in table 1. The mixing ingredients of 
0.5% chloramphenicol eye drops were conducted in the Laminar Air 
Flow (LAF) room. After all the raw materials have been dissolved 
and mixed in a 150 ml beaker glass that has been calibrated for 100 
ml, the initial pH check of the preparation was then carried out and 
then filtered with filter paper. The filtered solution was taken 5 ml of 
each using a syringe and then sterilized with sterile membrane filter 
bacteria and heating at a temperature of 98-100 °C for 30 min. After 
that, the sterilized eye drops were stored at room temperature for 
28 d. 
  
Table 1: 0.5% Chloramphenicol eye drop formula 
Composition Formula (%) 
B1 B2 B3 C1 C2 C3 
Chloramphenicol 0.50 0.50 0.50 0.50 0.50 0.50 
1.9% Boric acid 0.1805 0.171 0.149 0.1805 0.171 0.149 
2.65% Sodium tetraborate 0.01325 0.0265 0.0556 0.01325 0.0265 0.0556 
Thimerosal 0.01 0.01 0.01 0.01 0.01 0.01 
redistillata water Ad 100 ml Ad 100 ml Ad 100 ml Ad 100 ml Ad 100 ml Ad 100 ml 
pH 6.8 7.0 7.4 6.8 7.0 7.4 
Notes: B= sterilized using heating with a bactericide; C= sterilized using membrane filter; 1,2 and3= different pH 
 
Medium preparation  
Preparation of all agar media used in this study was done in the 
same preparation procedure of weighing an amount of media 
according to the appendix which listed in the medium bottle. The 
weighed media, then dissolved in 500 ml aquadest in 1000 beaker 
glass, heated and stirred until it dissolved. The media solution was 
then sterilized using the autoclave [24]. 
Microbial preparation for fertility, effectiveness and sterility 
test 
A loopful of each microbial colony was suspended in TSB (for B. 
subtilis) and SDB (For C. albicans), then incubated at 37 °C for 18 h 
(for B. subtilis) and 20-25 °C for 3 d (for C. albicans). The final 
microbial inoculum concentration was adjusted to 0.5 Mc Farland 
(1.5x108cfu/ml) then diluted by each broth media to achieve 1 x 
107cfu/ml. 0.5 McFarland solution was made by mixing a total of 
0.05 ml of 1% BaCl2 solution and 9.95 ml of 1% H2SO4
The fertility test is purposed to ensure that the used media free from 
inhibitor substances that may inhibit the microorganism growth. B. 
subtilis was used as a bacterial indicator and C. albicans as fungal 
indicator. The B. subtilis inoculating media was incubated at 30-35 
°C for 7 d, and the fungal medium was incubated at 20-25 °C for 3 d. 
This fertility test was performed after the standard dilution of 
microbial colonies for fertility testing. A volume of 1 ml cell 
suspension was poured into a sterile petri disk, then a total of 5 ml 
tested medium was added. The media was allowed to solidify, then 
incubated at each incubation condition, as previously mentioned 
[26].  
Media sterility test 
Sterile Tioglycolate and Soybean Casein media were incubated at 30-
35 °C for Tioglycolate and 20-25 °C for Soybean Casein for no less 
than 7d. The growth of bacteria or fungi was characterized by the 
presence of turbidity in the medium. 
Effectiveness test 
A total of 5 drops of eye drops preparation was put into two test 
tubes containing sterile tioglycolate media which had been 
inoculated with B. subtilis, then incubated at 30-35 °C for no less 
than 7 d. In two tubes containing Soybean Casein medium, C. 
albicans was inoculated and then added 5 drops of eyes drops 
preparations into the tubes and incubated at a temperature of 20-25 
°C for no less than 7 d. The turbidity of the tested media was 
observed [26]. 
Sterility test of eye drops 
 solution, then 
shaken to homogenize the solution. The solution turbidity was 
measured spectroscopically at a wavelength of 530 nm by using 
distilled water as a blank. 
Media fertility test Sterility testing of each eye drop formula was conducted by direct 
inoculation method and carried out in the LAF room. A volume of 2 
ml test preparation was dropped into each of 3 test tubes containing 
Tioglycolic media, then incubated at a temperature of 30-35 °C for 
no less than 14 d and the turbidity observed every day. The same 
procedure was also carried out in soybean casein media, but this 
medium was incubated at a temperature of 20-25 °C. In addition, 
positive, negative and sterility control of the media were made, 
which were incubated with the test media. 
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Evaluation of eye drops 
All eye drops formulas were evaluated for the clarity, pH values and 
antibiotic potency test, with an observation time on days of 
1,3,7,14,21 and 28 during storage. 
Clarity observation 
The clarity and the color change of all eye drops were observed 
visually during storage at room temperature.  
pH 
pH of the prepared eye drops solution was measured by a pH meter. 
Preparation of microbial suspension for potency test 
One Ose of E. coli colony was taken and suspended in sterile MHB 
then incubated at 37 °C for 18 h. The final cell suspension 
concentration was adjusted to 0.5 Mc Farland (1.5x108 cfu/ml). 0.5 
McFarland solution was made by mixing a total of 0.05 ml of 1% 
BaCl2 solution and 9.95 ml of 1% H2SO4
The potency test of chloramphenicol reference standard was done 
by agar diffusion method using 3+3 pattern. Reference standard of 
Chloramphenicol was accurately weighed of 25.0 mg and dissolved 
in ethanol and aquadest till the volume was 25 ml to achieve 1000 
mg/ml of chloramphenicol. The solution, then diluted to obtain 3 
standard solution with concentration of S1(25 µg/ml), S2 (50µg/ml) 
and S3 (100 µg/ml).  
 solution, then shaken to 
homogenize the solution. The solution turbidity was measured 
spectroscopically at a wavelength of 530 nm by using distilled water 
as a blank. 
Preparation of standard solution  
Preparation of sample solution 
Each formula of eye drops with different sterilization method was 
evaluated to determine the percentage of potency value during the 
storage time at room temperature. From each formula, a 20 ml of 
eyes drop was pippeted and diluted with aquadest into 100 ml 
volumetric flask, to obtain a concentration of 1000 mg/ml. The 
solution, then diluted to obtain 3 sample solution with concentration 
of U1(25 µg/ml), U2 (50µg/ml) and U3 (100 µg/ml).  
Potency test 
The potency test of chloramphenicol was conducted by the agar 
diffusion method using the perforator technique with a 3+3 dosage 
arrangement. A total of 20 µl E. coli suspension was suspended in 
MHA medium with a temperature of 45 °C, then the medium was 
homogenized and let the medium solidify at room temperature. The 
solid media were then perforated using perforator, thus 6 holes 
were present in the agar plate. Those holes were provided for 
sample and standard solution of chloramphenicol, each of 3 holes. 
Each hole was transferred with 50 µl of sample and standard 
solution of chloramphenicol and incubated for 18 h at 37 °C. The 
diameters of the inhibition zone were measured using a caliper. 
Statistical analysis 
The effect of different sterilization method was analyzed to determine its 
effect to the potency value in different pH solution using 2x3x5 factorial 
experimental design. The calculation can be seen in table 2. 
  
Table 2: Statistical analysis calculation 
Source of varians dk jk Rjk F cal F table 
mean 1 Ry Ry  Fα(dk,60) 
M m-1 My My/m-1=M M/MP F
P 
0,05(dk,60) 
p-1 Py Py/p-1=P P/E  
H h-1 Hy Hy/h-1=H H/PH  
MP (m-1)(p-1) MPy Mpy/(m-1)(p-1)=MP MP/E  
MH (m-1)(h-1) MHy Mhy/(m-1)(h-1)=MH MH/MPH  
PH (p-1)(h-1) PHy Phy/(p-1)(h-1)=PH PH/E  
MPH (m-1)(p-1)(h-1) MPHy MPHy/(m-1)(p-1)(h-1)=MPH MPH/E  
mistake  Ey Ey/mph(n-1)=E   
sum mphn Σy  2   
Notes: M= The effect of the sterilization method used in eye drops; P= Effect of pH variation; H= Effect of observation day; MP= Interaction effects 
between sterilization methods and pH variations; MH= Interaction effects between sterilization methods and observation days; PH= Interaction effects 
between variations in pH and observation days; MPH = Interaction effects between sterilization methods, variations in pH and observation days. 
 
RESULTS AND DISCUSSION 
Results of sterility, fertility and effectiveness test 
These tests were a series of steps with different purposes to 
evaluate the growth media to be used before the method of eyes 
drop sterilization was fully validated. The fertility test is 
important to ensure the ability of the media in supporting 
microbial growth [1]. The accurate and reproducible sterility 
test results will obtain by the using of growth media with high 
quality [27]. The sterility test is purposed to exhibit that the eye 
drop product is sterile. Meanwhile, the effectiveness test was 
aimed to demonstrate that the active ingredients in an eye drops 
did not provide antimicrobial activity against contaminants, so it 
can be ascertained that the sterility of the media was the result 
of the mechanism of the used sterilization methods.  
The results of these tests were shown in table 3. 
 
Table 3: The results of media sterility, fertility and effectiveness test 
Day of observation  Sterility test Fertility test Effectiveness test 
B C B C B C 
1 - - + + + + 
2 - - + + + + 
3 - - + + + + 
4 - - + + + + 
5 - - + + + + 
6 - - + + + + 
7 - - + + + + 
Notes: B= B. subtilis; C= C. albicans; (+) = turbid; (-) = clear  
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Based on the results of the fertility test, all media to be used for the 
sterility test of 0.5% chloramphenicol eye drop were defined as 
high-quality media, because it can support the growth of the tested 
microbial colonies. From the media sterility test, no microbial colony 
was a presence in all the tested media. This implied that the tested 
media were sterile. The sterility of the media was also supported by 
the result of effectiveness test that resulted in the growth of B. 
subtilis and C. albicans, even they were inoculated in the media 
containing eye drops with chloramphenicol as its active agent. Thus, 
it could be concluded that all the media were appropriate for the 
sterility test of eye drops. 
Sterility test results of eye drops 
All the eyes drops formulations were found to be sterile in both 
sterilization methods. The results were displayed in table 4. The 
sterilization method of heating was done by adding bactericidal 
substances to the preparation with a certain concentration and 
heated at a temperature of 98-100 °C for 30 min. Thus, this method 
can be used as a substitute for the sterilization method using an 
autoclave that requires a higher heating temperature, which is 121 
°C for 15 min. For the preparation of the eye drop solution, 
bactericides which may be used are benzalkonium chloride 0.1%, 
chlorhexidine, or thimerosal are used as substitutes for phenyl 
mercury. In selecting bactericidal substances, toxicity and 
compatibility with substances in the preparation must be considered 
and no interaction with the container [28]. In this study, thimerosal 
was served as the bactericide to against the contaminants before 
and after the sterilization process, especially the probable 
contamination that will occur during the product storage and use. 
The eye drop sterility was required to be maintained during the 
period of use [29]. This bactericide is an important substance to be 
formulated in the eye drops, because the contamination may lead to 
product degradation thus allowing pathogens to grow and cause eye 
infections [30]. Therefore, protection of the product, an especially 
sterile product like an eye drops is essential to improve the product 
against the opportunistic contamination effects by using appropriate 
preservatives. Thimerosal is one of common preservative, use in eye 
drops preparation. Meanwhile, the sterilization method using 
bacterial filter membrane is used to sterilize a solution that is 
unstable heat. The benefits of this sterilization method are filtering 
the solution in small amounts effectively, the used equipment is 
relatively cheap and can remove particles, living and dead microbes 
from solution. The disadvantages of this method include certain 
filters that allow the absorption of several active compounds and 
give basicity to the solution during the filtration process and the 
possibility of damage to the filter form which causes the filtering 
results not to be sterile. In addition, filtering with large volumes will 
require a longer time than using the other sterilization method [24]. 
 
Table 4: Sterility test results of eye drops 
Day of observation CM NC PC B B1 B2 C3 C1 C2 3 
Bs F Bs F Bs F Bs F Bs F Bs F Bs F Bs F Bs F 
1 - - - - + + - - - - - - - - - - - - 
2 - - - - + + - - - - - - - - - - - - 
3 - - - - + + - - - - - - - - - - - - 
4 - - - - + + - - - - - - - - - - - - 
5 - - - - + + - - - - - - - - - - - - 
6 - - - - + + - - - - - - - - - - - - 
7 - - - - + + - - - - - - - - - - - - 
8 - - - - + + - - - - - - - - - - - - 
9 - - - - + + - - - - - - - - - - - - 
10 - - - - + + - - - - - - - - - - - - 
11 - - - - + + - - - - - - - - - - - - 
12 - - - - + + - - - - - - - - - - - - 
13 - - - - + + - - - - - - - - - - - - 
14 - - - - + + - - - - - - - - - - - - 
Notes: CM= control media; NC= negative control; PC= positive control; B= sterilized using heating with a bactericide; C= sterilized using membrane 
filter; Bs=bacteria; F= fungi; 1,2 and3= different pH; (+) = turbid; (-) = clear  
 
Clarity  
The appearance of the eyes drops formulas of the both sterilization 
methods were analyzed. There was no change in color during the 
storage time. The results were shown in table 5. This implied that 
chloramphenicol did not undergo photodegradation reactions. The 
indication of the occurrence of this photodegradation reaction can 
be seen by the change in color of the solution from colorless to 
yellow until it formed a yellow-orange precipitate. But preparations 
B1 and C1 showed the presence of precipitates after 28th d of storage 
time. The precipitations occurred were estimated as hydrolytic 
degradation compounds from chloramphenicol due to the effect of 
pH and heating. Another study reported that a lower pH increasing 
degradation of chloramphenicol and the highest degradation 
efficiency was achieved at pH 2.96 [31]. The precipitate formed on 
B1 preparations was greater than C1
Day of observation 
 preparation. This showed in 
the same pH, the heating process in the sterilization method can 
accelerate the hydrolytic degradation reaction of chloramphenicol. 
 
Table 5: Clarity observation results 
Color and sediment formation of the eyes drop 
B B1 B2 C3 C1 C2 3 
1 -(cl) -(cl) -(cl) -(cl) -(cl) -(cl) 
3 -(cl) -(cl) -(cl) -(cl) -(cl) -(cl) 
7 -(cl) -(cl) -(cl) -(cl) -(cl) -(cl) 
14 -(cl) -(cl) -(cl) -(cl) -(cl) -(cl) 
28 ++(cl) -(cl) -(cl) +(cl) -(cl) -(cl) 
Notes: B= sterilized using heating with a bactericide; C= sterilized using membrane filter; 1,2 and3= different pH, cl=colorless; (-) = precipitate 
absence; (+) = precipitate presence. 
 
pH stability 
The pH of the eyes drops formulation is very important mainly to 
prevent eye discomfort or pain after the eye drops used. In eyes 
drops formulation, the pH value must be considered to rely on the 
acceptable range of eye pH. The optimum pH for eye drops is 7.4 
that equals tear fluid pH range, but other studies mentioned that the 
pH range of 4–8 was the normal pH of the eyes and the pH of an eye 
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between pH 5.5-11.4 can still be accepted [32, 33]. The pH 
incompatibility in eyes may cause irritation and the drug 
bioavailability decreased because the tearing was increased [32]. 
Thus, the pH of eye drops must be adjusted to comply with the range 
of suitable pH for the eyes [34]. In addition, the different pH of eye 
drops effected the stability of the active substance. A lower pH of 
preparations containing chloramphenicol made the increasing of 
chloramphenicol degradation [31]. Therefore, pH of eye drops 
containing chloramphenicol was formulated in variations of pH in 
the range of 6.8-7.4 to determine the compatible pH value of the 
eyes drop. The pH stability of each formula with different 
sterilization method was shown in table 6 and fig. 1. 
  
Table 6: pH stability 
Day of observation pH 
B B1 B2 C3 C1 C2 3 
0 6.80 7.08 7.41 6.80 7.08 7.41 
1 6.78 7.07 7.39 6.80 7.08 7.40 
3 6.77 7.04 7.37 6.79 7.06 7.37 
7 6.74 7.04 7.36 6.77 7.05 7.35 
14 6.72 7.03 7.33 6.74 7.04 7.34 
28 6.70 7.01 7.32 6.71 7.03 7.33 
Notes: B= sterilized using heating with a bactericide; C= sterilized using membrane filter; 1,2 and3= different pH 
 
 
Fig. 1: pH stability results 
 
Based on the data in table 6 and fig. 1, it can be seen that all preparations 
have decreased in pH value. But, the pH decreasing of the eye drops 
which sterilized using heating with bactericide were greater than using a 
sterile bacterial filter membrane sterilization method. The longer the 
storage time, the price of the pH of the dosage will decrease even though 
the preparation has been added to borate as a pH stabilizer, but in reality 
the values of pH decreased after storage for 28 d. These could be caused 
by the hydrolysis of chloramphenicol during storage as reported in 
another study that the stability of chloramphenicol was independent of 
pH between 4 to 6.2, and it was susceptible to hydrolysis in aqueous 
media [35]. From the data above, it can be seen that C2 preparations at 
pH 7.0 and sterilized using the bacterial filter sterilization method are 
more stable because they had the smallest pH change of 0.05. However, 
all pH of eyes drops formulas from both sterilization methods still 
complies the acceptable pH of the eye drops. 
Potency test results 
Stability of drug is a great importance factor that must be considered 
for its efficacy. The antibiotic effectiveness is described in the terms 
of potency value, thus, the accurate measurement of antibiotic 
potency is a critical step to ensure the antibiotics quality [36]. A mild 
change in the concentration of active components in preparations 
containing antibiotic may have impact in actual efficacy and 
contributed in the resistance cases [37, 38]. Therefore, 
quantification of chloramphenicol in these eye drop preparations 
was very important. Based on the data in table 7 and fig. 2, it can be 
concluded that the C2 preparations, which were formulated at pH 
7.0 and sterilized using the bacterial filter membrane sterilization 
method, were more stable because the potential reduction 
percentage was smaller than the other formulas. 
 
Table 7: Potency test results 
Day of observation Potency (%) 
B B1 B2 C3 C1 C2 3 
1 97.72 98.86 98.17 97.50 98.63 98.40 
3 96.38 97.72 97.50 96.38 98.62 98.17 
7 97.72 97.50 96.82 93.97 98.40 97.28 
14 90.57 96.82 94.62 90.57 97.72 95.71 
28 88.31 96.61 94.40 89.33 97.50 95.94 
Notes: B= sterilized using heating with a bactericide; C= sterilized using membrane filter; 1,2 and3= different pH 
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Fig. 2: Potency stability results 
 
Statistical analysis result 
This statistical analysis was aimed to determine the effect of 
sterilization methods and variations in the pH of the eyes drops 
preparation on the stability of chloramphenicol potency. Statistical 
testing using 2x3x5 factorial experimental design with the assumption 
that the model used is a mixed model with two factor levels of the 
sterilization method (sterilization method B which is heating with 
bactericidal addition at certain temperature and C method sterilization 
using bacterial filter membrane), three levels of variation pH (pH 6. 
80; pH 7.0 and pH 7.4) and five observational day factor levels (1, 3, 7, 
14 and 28 d). The results of statistical testing using the 2x3x5 factorial 
experimental design can be seen in table 8. From these results, it can 
be concluded that there was a difference in the chloramphenicol 
potency due to variations in pH during storage time, while for other 
factors did not indicate an effect on potency difference. 
  
Table 8: Statistical analysis result 
Source of varians dk jK RJK F cal F table 
mean 1 833332.600 833332.600  Fα(dk,60) 
M 1 0.013 0.013 0.001 4.00 
P 2 220.214 110.107 11.624 3.15 
H 4 248.711 62.178 4.245 2.53 
MP 2 20.432 10.216 1.079 3.15 
MH 4 6.136 1.534 0.416 2.53 
PH 8 117.175 14.647 1.546 2.10 
MPH 8 29.515 3.689 0.389 2.10 
mistakes 60 568.340 9.472   
Sum  90 834543.100    
 
CONCLUSION 
In conclusion, variations in the sterilization method did not give a 
significant difference in the efficacy of chloramphenicol. In contrast, 
the variation in pH gives a significant difference in the 
chloramphenicol potency during storage. Based on the results, the 
most stable formula for chloramphenicol eye drops was the 
preparation at pH 7.0 and sterilized using a bacterial filter membrane.  
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